12:42 PM
 | 
Apr 21, 2017
 |  BioCentury  |  Finance

Sowing French seeds

How Advent France tech transfer fund will apply IP commercialization model in France

With the largest tech transfer fund in the country, Advent France Biotechnology is aiming to apply the academic IP commercialization model on a much larger scale than has previously been done in France.

On April 20, the firm announced the €64.8 million ($68.9 million) first close of Advent France Biotechnology Seed-Fund I, exceeding the €60 million ($63.8 million) target.

The majority of the capital came from three institutional funds-of-funds: Fonds...

Read the full 339 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >